-+ 0.00%
-+ 0.00%
-+ 0.00%

Len Blavatnik And Access Industries Report 10.4% Stake In Hemab Therapeutics As Of May 4, 2026

Benzinga·05/11/2026 21:04:45
Listen to the news

- SEC Filing